Related Experiment Videos
The impact of D-Trp6 LH-RH on plasma lipid levels
G A Goldman1, A Schoenfeld, J Ovadia
1Department of Obstetrics and Gynecology, Beilinson Medical Center, Petah-Tikva, Israel.
Insights
Short-term use of gonadotropin-releasing hormone (GnRH) analogues like D-Trp6 LH-RH does not significantly alter key lipid levels, including HDL-cholesterol and triglycerides. Further research is needed for long-term safety assessment in specific patient groups.
Area of Science:
- Reproductive Endocrinology
- Cardiovascular Risk Assessment
- Lipid Metabolism
Background:
- Cardiovascular disease risk is linked to abnormal lipid profiles (HDL-cholesterol, LDL-cholesterol, triglycerides).
- Gonadotropin-releasing hormone (GnRH) analogues are commonly used in assisted reproduction.
- Evaluating the impact of GnRH analogues on serum lipoprotein levels is crucial.
Purpose of the Study:
- To assess lipoprotein changes after administration of the long-acting GnRH analogue, D-Trp6 luteinizing hormone-releasing hormone (LH-RH).
Main Methods:
- Serum levels of total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglycerides were measured.
- Measurements were taken before and after a 6-week treatment period with D-Trp6 LH-RH.
- The study included 25 patients.
Main Results:
- No statistically significant alterations in cholesterol, HDL-cholesterol, LDL-cholesterol, or triglycerides were observed.
- Treatment with D-Trp6 LH-RH did not impact the measured lipid parameters in the study group.
Conclusions:
- Short-term administration of D-Trp6 LH-RH shows no significant effect on plasma lipid levels.
- Long-term safety regarding lipid metabolism requires further investigation, especially in patients with pre-existing high lipid levels undergoing repeated treatment cycles.
Background:
There is increasing evidence regarding the correlation between the risk of death from cardiovascular disease and low levels of HDL-cholesterol or high plasma concentrations of LDL-cholesterol, total cholesterol, and triglycerides. Gonadotropin releasing hormone (GhRH) analogues are widely used in assisted reproduction programs. Therefore, it seems important to evaluate possible changes in serum lipoprotein levels following treatment with these compounds.
Purpose:
Our purpose was to assess possible lipoprotein changes following administration of the long-acting GnRH analogue, D-Trp6 luteinizing hormone-releasing hormone (LH-RH).
Design:
Serum levels of cholesterol, HDL-cholesterol, LDL-cholesterol, and triglicerydes were determined before and after 6 weeks of treatment.
Results:
No significant changes in either cholesterol or HDL-cholesterol, LDL-cholesterol, or triglicerydes following treatment with D-Trp6 LH-RH were demonstrated in the group of 25 patients investigated.
Conclusions:
Short-term use of D-Trp6 LH-RH is not associated with any significant change in plasma lipid levels. Further studies are still required with patients undergoing repeated treatment cycles, especially those who exhibit elevated pretreatment plasma lipid levels, to confirm the long-term safety of GnRH analogues with respect to lipid metabolism.